112 related articles for article (PubMed ID: 339937)
1. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
Forrest WA
Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
[No Abstract] [Full Text] [Related]
2. [Evaluation of the hypotensive effect of slow-release Trasicor].
Cybulska I; Brym E
Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
[No Abstract] [Full Text] [Related]
3. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
O'Brien KP; Stephens EJ
N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
[TBL] [Abstract][Full Text] [Related]
4. Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice.
Forrest WA
J Int Med Res; 1979; 7(4):318-23. PubMed ID: 488521
[No Abstract] [Full Text] [Related]
5. [Slow-release oxprenolol and chlortalidone administered once daily in essential hypertension].
Rossi A; Ziacchi V; Fracalossi C; Marino A; Lomanto B
Minerva Cardioangiol; 1984 Dec; 32(12):949-62. PubMed ID: 6531101
[No Abstract] [Full Text] [Related]
6. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
Forrest WA; Bridgman KM; Ebbutt AF
Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
[No Abstract] [Full Text] [Related]
7. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
Cybulska I; Sznajderman M
Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
[No Abstract] [Full Text] [Related]
8. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
Elsdon-Dew RW; Holden E
J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
[No Abstract] [Full Text] [Related]
9. European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
Eur Heart J; 1982 Dec; 3(6):583-6. PubMed ID: 6761123
[No Abstract] [Full Text] [Related]
10. [Treatment of hypertrophic cardiomyopathy with a delayed-action preparation of Trasicor].
Dabrowski M; Bijak A; Letowski A; Rydlewska-Sadowska W; RuzyłłO W; Hoffman M
Kardiol Pol; 1984; 27(7):579-89. PubMed ID: 6392686
[No Abstract] [Full Text] [Related]
11. Can once daily dosage be effective in the treatment of hypertension throughout 24 hours? A controlled evaluation of sustained release oxprenolol.
Volan GN; Rogers HJ; House F
Br J Clin Pharmacol; 1979 Jul; 8(1):86-9. PubMed ID: 399593
[No Abstract] [Full Text] [Related]
12. A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
Forrest WA
J Int Med Res; 1978; 6(2):136-40. PubMed ID: 631415
[TBL] [Abstract][Full Text] [Related]
13. [A multicenter clinical comparison study between Tevacor and Trasicor in hypertension].
Shmueli H; Rosenfeld J
Harefuah; 1986 Jun; 110(11):550-2. PubMed ID: 3533738
[No Abstract] [Full Text] [Related]
14. [Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
Gambini G; Pizzuti C; Valori C
Clin Ter; 1988 Feb; 124(3):203-10. PubMed ID: 2974332
[No Abstract] [Full Text] [Related]
15. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
Albanesi Filho FM; Benchimol AB
Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
[No Abstract] [Full Text] [Related]
17. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
Forrest WA
Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
[No Abstract] [Full Text] [Related]
18. [Oxprenolol in the treatment of essential arterial hypertension].
Soto Rojas G
Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
[No Abstract] [Full Text] [Related]
19. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
20. [Slow trasicor in the treatment of essential hypertension].
Giec L; Sledziński Z; Trusz-Gluza M; Nieszporek T; Hübner D; Mleczko Z; Olwiński M
Kardiol Pol; 1981; 24(9):625-30. PubMed ID: 7300086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
